sumatriptan has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Headache is one of the most common symptoms of COVID." | 2.82 | Post-COVID Headache: A Literature Review. ( Chhabra, N; Grill, MF; Singh, RBH, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhabra, N | 1 |
| Grill, MF | 1 |
| Singh, RBH | 1 |
| Vandebosch, C | 1 |
| Dupont, M | 1 |
| Verhaert, D | 1 |
| Mullens, W | 1 |
1 review available for sumatriptan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Post-COVID Headache: A Literature Review.
Topics: COVID-19; Epilepsy; Female; Headache; Humans; Migraine Disorders; Sumatriptan | 2022 |
1 other study available for sumatriptan and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist in a patient with new-onset Graves' disease and myocarditis after SARS-CoV2 vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; Coronary Vasospasm; COVID-19; COVID-19 Vaccines; Graves Disease; Humans | 2023 |